• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SMART TRANSMITTER; IMPLANTABLE GLUCOSE MONITORING SYSTEM, TRANSMITTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SMART TRANSMITTER; IMPLANTABLE GLUCOSE MONITORING SYSTEM, TRANSMITTER Back to Search Results
Model Number 102208-005
Device Problem Imprecision (1307)
Patient Problems Hypoglycemia (1912); Unspecified Infection (1930)
Event Date 05/09/2019
Event Type  Injury  
Event Description
Senseonics was made aware of an instance wherein a patient using the eversense cgm system visited his healthcare professional due to a stomach viral infection.During the visit with his doctor, the patient's eversense sensor was indicating a drop in sensor glucose readings from 140mg/dl to 107 mg/dl between 12:00pm and 12:30pm.The patient's doctor then administered glucose to the patient.The patient has not reported if his doctor administered the glucose based on the patient's eversense sensor reading or based on a blood glucose test reading.After leaving the doctor, the patient became ill around 1:00pm and 2:00pm and was taken to the hospital by his caregiver where his blood glucose was at 1070 mg/dl.The patient has not reported if the eversense cgm system provided any alerts during his doctor's visit or prior to his visit at the hospital.The patient is no longer at the hospital and has recovered.
 
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.Its not known whether the cgm system provided any alerts during his doctor's visit or prior to his visit at the hospital.Patient has recovered.No further follow up from the patient was received to make a decision.No remedial action/corrective action/preventive action / field safety corrective action is required.No further follow up from the patient was received to make a decision.Based on the available information, patient has recovered after visiting the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SMART TRANSMITTER
Type of Device
IMPLANTABLE GLUCOSE MONITORING SYSTEM, TRANSMITTER
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18400674
MDR Text Key331421873
Report Number3009862700-2023-00378
Device Sequence Number1
Product Code QCD
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/22/2019
Device Model Number102208-005
Device Catalogue NumberFG-3400-XX-XXX
Device Lot Number109181
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/07/2019
Initial Date FDA Received12/27/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/22/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-